J0701
HCPCSInj. cefepime hcl (baxter)
Official HCPCS Level II long descriptor
Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
HCPCS Level II code J0701 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj. cefepime hcl (baxter)
Added to HCPCS: 2023-01-01
Nearby codes in J0
- J0691Inj lefamulin 1 mg
- J0692Cefepime hcl for injection
- J0694Cefoxitin sodium injection
- J0695Inj ceftolozane tazobactam
- J0696Ceftriaxone sodium injection
- J0697Sterile cefuroxime injection
- J0698Cefotaxime sodium injection
- J0699Inj, cefiderocol, 10 mg
- J0702Betamethasone acet&sod phosp
- J0703Inj, cefepime hcl (b braun)
- J0706Caffeine citrate injection
- J0712Ceftaroline fosamil inj
- J0713Inj ceftazidime per 500 mg
- J0714Ceftazidime and avibactam
- J0716Centruroides immune f(ab)
- J0717Certolizumab pegol inj 1mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.